1. YL Liu, X Wang, N Krishnan, T HSiao, YC Ji, K kenako, MG Teneche, PD Adams, E Zuniga, SM Kaech, LF Zhang and GS Feng. Efficacious suppression of primary and metastasized liver tumors by polyIC-loaded nanoparticles. Hepatology, Accepted, 2025.

2. WS Chen, Y Liang, M Zong, JJ Liu, K Kaneko, KL Hanley, K Zhang, and GS Feng. Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment. Cell Reports, 2021 Vol. 37 Issue 6 Pages 109974

3. Liang, Y, K Kaneko, B Xin, J Lee, X Sun, K Zhang, and GS Feng. Temporal analysis of postnatal liver development and maturation by single cell transcriptomics. Developmental Cell. 57, 398-414, 2022

4. K Kaneko, Y Liang, Q Liu, S Zhang, A Scheiter, D Song, and GS Feng. Identification of CD133+ intercellsomes in intercellular communication to offset intracellular signal deficit. eLife. 12, Epub on Oct 17, 2023. Accession Number: 37846866, DOI: 10.7554/eLife.86824

5. Bard-Chapeau EA, S Li, J Ding, SS Zhang, HH Zhu, F Princen, DD Fang, T Han, B Bailly-Maitre, V Poli, NM Varki, H Wang and GS Feng. PTPN11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell19, 629-639, 2011.

6. Feng GS, CC Hui, and T Pawson. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science 259, 1607-11, 1993.